The Financial Reporting Council (FRC) has issued amendments to Financial Reporting Standards (FRS) 102, the financial reporting standard for the UK and the Republic of Ireland.
The amendments anticipated to have the strongest impact on financial statements, are those which align with IFRS 16 Leases and IFRS 15 Revenue from Contracts with Customers.
In our latest paper, "UK GAAP is Changing: Are You Ready?” we help business leaders stay ahead of these changes, by asking pertinent questions and detailing tangible accounting scenarios.
Discover:
- Why these changes matter to you: Financial Reporting, Contracts & Systems, Strategic Implications
- Key dates: Final amendments, Early application, Effective date
- Changes with FRS 102: IFRS Section 20 vs 23
- Steps to get started: Key questions businesses should be asking
- How A&M can help: Our team specialises in supporting businesses navigate accounting changes with clarity and precision
DOWNLOAD THE FULL PAPER
Canada’s Private Capital Outlook 2026: Infrastructure, Insight, and Operational Alpha
May 19, 2026
Canadian private capital enters 2026 in a state of disciplined optimism. The environment is more selective, more data-driven, and significantly more execution-focused than in prior cycles.
Infrastructure Pulse Survey Report: Spring 2026, North America and Europe
May 14, 2026
The Infrastructure Pulse Survey Report for Spring 2026, published by Alvarez & Marsal in collaboration with the Global Infrastructure Investor Association (GIIA), offers an insight into how investors across North America and Europe are reading the current investment landscape through a period of macroeconomic and geopolitical uncertainty.
Alvarez & Marsal Continues to Strengthen Transaction Advisory Practice in Australia with Senior Talent
May 13, 2026
Alvarez & Marsal (A&M), a leading global professional services firm, today announced the appointment of Sydney-based Roshan Emmanuel as a Managing Director within its Global Transaction Advisory Group (Global TAG), underscoring the firm’s rapid growth and continued investment in the Australian market.
Carving Out Success: Life Sciences Companies Are Rationalizing Portfolios by Divesting Non-Core Assets
May 12, 2026
Historically, large healthcare and life sciences corporations have focused deal activity on a breadth of diverse assets. However, the landscape is undergoing significant transformation as businesses shift to rationalize their portfolios and invest in fewer core areas.
